Drugs / INCB000631
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07039929 | Jul → Oct 2025 | — | Incyte Corporation | Terminated | No outcome recorded Stop: Business |
| Phase 1 | NCT06775327 | Feb → May 2025 | — | Incyte Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INCB000631 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06775327 ↗ |
| Route | Oral | “Oral; Tablet” NCT06775327 ↗ |